Matthew L. Baum

5.9k total citations · 2 hit papers
33 papers, 3.6k citations indexed

About

Matthew L. Baum is a scholar working on Cancer Research, Cognitive Neuroscience and Oncology. According to data from OpenAlex, Matthew L. Baum has authored 33 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Cognitive Neuroscience and 5 papers in Oncology. Recurrent topics in Matthew L. Baum's work include Breast Cancer Treatment Studies (7 papers), Neuroethics, Human Enhancement, Biomedical Innovations (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Matthew L. Baum is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Neuroethics, Human Enhancement, Biomedical Innovations (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Matthew L. Baum collaborates with scholars based in United States, United Kingdom and Czechia. Matthew L. Baum's co-authors include Steven A. McCarroll, Nolan Kamitaki, Heather de Rivera, Vanessa Van Doren, Giulio Genovese, Beth Stevens, Samuel A. Rose, Robert E. Handsaker, Katherine Tooley and Michael C. Carroll and has published in prestigious journals such as Nature, Cell and Journal of Neuroscience.

In The Last Decade

Matthew L. Baum

28 papers receiving 3.5k citations

Hit Papers

Schizophrenia risk from complex variation of complement c... 2016 2026 2019 2022 2016 2018 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew L. Baum United States 13 1.3k 828 747 687 511 33 3.6k
Moritz J. Rossner Germany 39 2.9k 2.2× 1.2k 1.5× 1.5k 2.1× 567 0.8× 221 0.4× 115 6.1k
Jacinta Lucero United States 22 1.8k 1.3× 593 0.7× 567 0.8× 233 0.3× 244 0.5× 25 3.4k
Pavel Katsel United States 32 1.7k 1.3× 523 0.6× 535 0.7× 478 0.7× 379 0.7× 59 3.2k
Mina Ryten United Kingdom 37 2.2k 1.6× 895 1.1× 908 1.2× 741 1.1× 138 0.3× 80 4.5k
Matthew H. Bailey United States 25 3.1k 2.3× 2.2k 2.7× 924 1.2× 457 0.7× 435 0.9× 35 6.3k
Timothy R. Hammond United States 14 1.2k 0.9× 2.1k 2.6× 636 0.9× 470 0.7× 712 1.4× 18 4.3k
Jeffrey L. Dupree United States 47 3.0k 2.3× 1.3k 1.6× 2.3k 3.1× 279 0.4× 310 0.6× 99 6.8k
Paolo Guarnieri United States 20 3.0k 2.2× 1.6k 1.9× 1.0k 1.4× 363 0.5× 204 0.4× 31 5.8k
Shuyun Deng China 8 1.8k 1.3× 1.5k 1.8× 953 1.3× 263 0.4× 200 0.4× 19 3.8k
Steven G. Kernie United States 33 2.5k 1.9× 759 0.9× 1.7k 2.2× 445 0.6× 109 0.2× 79 6.8k

Countries citing papers authored by Matthew L. Baum

Since Specialization
Citations

This map shows the geographic impact of Matthew L. Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. Baum more than expected).

Fields of papers citing papers by Matthew L. Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew L. Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. Baum. The network helps show where Matthew L. Baum may publish in the future.

Co-authorship network of co-authors of Matthew L. Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew L. Baum. A scholar is included among the top collaborators of Matthew L. Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew L. Baum. Matthew L. Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shlobin, Nathan A., Julian Savulescu, & Matthew L. Baum. (2024). The ethical landscape of human brain organoids and a mindful innovation framework. Nature Reviews Bioengineering. 2(9). 785–796. 4 indexed citations
2.
Baum, Matthew L. & Christopher M. Bartley. (2024). Human-derived monoclonal autoantibodies as interrogators of cellular proteotypes in the brain. Trends in Neurosciences. 47(10). 753–765. 1 indexed citations
3.
Baum, Matthew L., Alik S. Widge, Linda L. Carpenter, et al.. (2024). Pharmacogenomic Clinical Support Tools for the Treatment of Depression. American Journal of Psychiatry. 181(7). 591–607. 9 indexed citations
4.
Hsu, Michael, et al.. (2022). Incidental Findings from Deep Phenotyping Research in Psychiatry: Legal and Ethical Considerations. Cambridge Quarterly of Healthcare Ethics. 31(4). 482–486. 1 indexed citations
5.
Baum, Matthew L., et al.. (2021). Falling through the cracks: Missed opportunities for diagnosing and treating lupus in schizophrenia. Schizophrenia Research. 238. 185–187.
6.
Saunders, Arpiar, Evan Z. Macosko, Alec Wysoker, et al.. (2018). Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain. Cell. 174(4). 1015–1030.e16. 943 indexed citations breakdown →
7.
Sekar, Aswin, Heather de Rivera, Timothy R. Hammond, et al.. (2016). Schizophrenia risk from complex variation of complement component 4. Nature. 530(7589). 177–183. 1548 indexed citations breakdown →
8.
Goebel-Goody, Susan, Matthew L. Baum, Constantinos D. Paspalas, et al.. (2011). Therapeutic Implications for Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Neuropsychiatric Disorders. Pharmacological Reviews. 64(1). 65–87. 127 indexed citations
9.
Baum, Matthew L.. (2011). The Monoamine Oxidase A (MAOA) Genetic Predisposition to Impulsive Violence: Is It Relevant to Criminal Trials?. Neuroethics. 6(2). 287–306. 24 indexed citations
10.
Baum, Matthew L., Pradeep Kurup, Jian Xu, & Paul J. Lombroso. (2010). A STEP forward in neural function and degeneration. Communicative & Integrative Biology. 3(5). 419–422. 12 indexed citations
11.
Xu, Jian, Pradeep Kurup, Yong Zhang, et al.. (2009). Extrasynaptic NMDA Receptors Couple Preferentially to Excitotoxicity via Calpain-Mediated Cleavage of STEP. Journal of Neuroscience. 29(29). 9330–9343. 225 indexed citations
12.
Potyka, Ingrid, et al.. (2001). Prophylactic radiotherapy following surgery for early breast cancer - is the benefit mainly to patients with involved margins? Results from a Cancer Research Campaign Trial. UCL Discovery (University College London). 2 indexed citations
13.
Baum, Matthew L.. (2000). The Anastrozole, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial in post-menopausal women: Regional variation in knowledge of hormone receptor status prior to randomisation into the trial: The ATAC Trialists’ Group. UCL Discovery (University College London). 1 indexed citations
14.
Baum, Matthew L.. (1984). Resection line disease in stomach cancer. BMJ. 289(6449). 919.3–920. 17 indexed citations
15.
Le, Hughes, et al.. (1977). The operative management of subclinical breast cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 3(2). 165–9. 17 indexed citations
16.
Baum, Matthew L.. (1976). The curability of breast cancer.. BMJ. 1(6007). 439–442. 47 indexed citations
17.
Kedem, J., Itamar Levinger, Matthew L. Baum, & S. Rogel. (1975). Heart Rate and Myocardial Substrate Preference During Normal and Hypoxic Perfusion of the Heart in Vivo. Archives Internationales de Physiologie et de Biochimie. 83(1). 53–62. 1 indexed citations
18.
Le, Hughes, et al.. (1974). Proceedings: Studies on breast pain.. PubMed. 61(4). 322–322. 1 indexed citations
19.
Unger, Anke, et al.. (1971). The potentiating effect of x-irradiation on the induction of experimental tumours in mice.. PubMed. 58(4). 303–303. 1 indexed citations
20.
Baum, Matthew L., et al.. (1970). Medullary Carcinoma of Breast. BMJ. 3(5721). 521.2–521. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026